SCHEMBL1775142

SCHEMBL1775142

Fc1cc(Br)ccc1OCCCN1CCCCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 7/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
ATM Q13315 1/20 0.55
LTA4H P09960 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
LMNA P02545 1/20 0.51
KDM1A O60341 1/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1776658 1.00 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL3575918 1.00 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL1821648 0.99 KDM4E (0.57) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL227430 0.93 LTA4H (0.60) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL226018 0.93 LTA4H (0.60) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL2322184 0.91 LTA4H (0.61) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL1821541 0.86 KDM4E (0.67) ALDH1A1KDM4ECYP2D6CYP1A2SMN1; SMN2
SCHEMBL1776537 0.85 L3MBTL1 (0.44) ALDH1A1KDM4EMEN1KMT2ACYP2D6
SCHEMBL28095208 0.84 KDM4E (0.49) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL14568590 0.83 KDM4E (0.56) ALDH1A1KDM4EMEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 EP disclosed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD ALDH1A1 1149/4885KDM4E 2604/4885MEN1 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.